November 12, 2013
 

Elanco expands cattle vaccine portfolio with Titanium and Master Guard
 

Elanco, the animal health division of Eli Lilly and Company announced the company will purchase the Titanium^® and Master Guard^® cattle vaccine brands from AgriLabs^®.

These vaccine brands will complement Elanco's growing vaccine portfolio, including the recently approved ViralignTM 6, the only modified-live combination vaccine to protect against bovine viral diarrhoea (BVD) virus 1b, which is now the most predominant BVD virus strain in the United States.

Elanco will work closely with AgriLabs to ensure a seamless transition and will support all 2013 programmes and pricing.

"At Elanco, we are committed to providing innovative solutions to enhance food production and companion animal care. We are pleased our growing vaccine portfolio and pipeline will offer Elanco customers a broader array of options to better meet their specific needs for disease prevention," said Jeff Simmons, president, Elanco. "This is another example of our effort to provide Elanco customers with greater value."

 "With beef stocks at all-time lows and demand outpacing dairy supply globally, we must continue to provide innovative solutions that will help producers increase the affordability and availability of animal protein," said Rob Aukerman, president US operations at Elanco. "We have diversified our portfolio and sources of innovation to deliver more options and solutions to our customers."

AgriLabs is a animal health, sales and marketing organisation with distribution throughout the United States. Through technology transfer and cooperative development agreements, AgriLabs has introduced state-of-the-art products for beef, dairy and companion animal industries.